Literature DB >> 8505107

Kinin actions on renal papillary blood flow and sodium excretion.

D L Mattson1, A W Cowley.   

Abstract

Infusion of bradykinin into the renal medullary interstitium (0.1 micrograms/min, n = 6) significantly increased renal papillary blood flow as measured by laser-Doppler flowmetry to 117 +/- 3% of control without altering cortical blood flow or blood pressure in anesthetized Munich-Wistar rats. In animals prepared for clearance studies, renal medullary bradykinin infusion did not alter total renal blood flow, glomerular filtration rate, or renal interstitial hydrostatic pressure but increased urine flow by 100%, sodium excretion by 111%, and fractional sodium excretion by 107%. No changes occurred in mean arterial pressure or contralateral kidney function during the interstitial bradykinin infusion. Blockade of endogenous kinin degradation by interstitial infusion of captopril (1 mg/hr) significantly increased papillary blood flow by 21 +/- 5% without altering cortical blood flow. Pretreatment with the nitric oxide inhibitor NG-nitro-L-arginine-methyl ester (2 micrograms/min, n = 7) eliminated the increase in papillary blood flow associated with either bradykinin or captopril infusion. We conclude that renal medullary interstitial infusion of bradykinin increases sodium and water excretion, which is associated with a selective increase in papillary blood flow by a nitric oxide-dependent mechanism.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8505107     DOI: 10.1161/01.hyp.21.6.961

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  10 in total

1.  The risk of bradykinin B2 receptor-58T/C gene polymorphism on hypertension: a meta-analysis.

Authors:  Kaiping Luo; Wenling Kang; Gaosi Xu
Journal:  Int J Clin Exp Med       Date:  2015-11-15

2.  Blockade of renal medullary bradykinin B2 receptors increases tubular sodium reabsorption in rats fed a normal-salt diet.

Authors:  Sema-Hayriye Sivritas; David W Ploth; Wayne R Fitzgibbon
Journal:  Am J Physiol Renal Physiol       Date:  2008-07-16

3.  The effects of angiotensin II on blood perfusion in the rat renal papilla.

Authors:  L L Walker; A A Rajaratne; J R Blair-West; P J Harris
Journal:  J Physiol       Date:  1999-08-15       Impact factor: 5.182

4.  Bradykinin-induced chloride conductance in murine proximal tubule epithelial cells.

Authors:  Manish M Tiwari; Joseph R Stimers; Philip R Mayeux
Journal:  Mol Cell Biochem       Date:  2006-09-27       Impact factor: 3.396

5.  Bradykinin acutely inhibits activity of the epithelial Na+ channel in mammalian aldosterone-sensitive distal nephron.

Authors:  Oleg Zaika; Mykola Mamenko; Roger G O'Neil; Oleh Pochynyuk
Journal:  Am J Physiol Renal Physiol       Date:  2011-02-16

6.  Salt-dependent inhibition of epithelial Na+ channel-mediated sodium reabsorption in the aldosterone-sensitive distal nephron by bradykinin.

Authors:  Mykola Mamenko; Oleg Zaika; Peter A Doris; Oleh Pochynyuk
Journal:  Hypertension       Date:  2012-10-01       Impact factor: 10.190

7.  Evidence against a crucial role of renal medullary perfusion in blood pressure control of hypertensive rats.

Authors:  Bożena Bądzyńska; Iwona Baranowska; Olga Gawryś; Janusz Sadowski
Journal:  J Physiol       Date:  2018-11-10       Impact factor: 5.182

8.  Differential action of bradykinin on intrarenal regional perfusion in the rat: waning effect in the cortex and major impact in the medulla.

Authors:  Bozena Badzyńska; Janusz Sadowski
Journal:  J Physiol       Date:  2009-06-15       Impact factor: 5.182

Review 9.  A Novel Category of Anti-Hypertensive Drugs for Treating Salt-Sensitive Hypertension on the Basis of a New Development Concept.

Authors:  Makoto Katori; Masataka Majima
Journal:  Pharmaceuticals (Basel)       Date:  2010-01-07

10.  Vhl deletion in renal epithelia causes HIF-1α-dependent, HIF-2α-independent angiogenesis and constitutive diuresis.

Authors:  Désirée Schönenberger; Michal Rajski; Sabine Harlander; Ian J Frew
Journal:  Oncotarget       Date:  2016-09-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.